#Effectiveness of BNT162b2 #LP81-adapted #SARS-CoV-2 #vaccine against #COVID19 associated #hospitalisation and #death: a Danish nationwide cohort study, www.thelancet.com/journals/lan...
...vaccine offered good protection over a 4-month period against COVID-19 hospitalisation and death.
...vaccine offered good protection over a 4-month period against COVID-19 hospitalisation and death.
Effectiveness of the BNT162b2 LP.8.1-adapted SARS-CoV-2 vaccine against COVID-19-associated hospitalisation and death: a Danish nationwide cohort study
On July 25, 2025, the European Medicines Agency approved the latest BNT162b2 mRNA
SARS-CoV-2 vaccine targeting the LP.8.1 omicron subvariant.1 The vaccine was offered
free-of-charge between Oct 1 and ...
www.thelancet.com
May 14, 2026 at 8:22 AM
#Effectiveness of BNT162b2 #LP81-adapted #SARS-CoV-2 #vaccine against #COVID19 associated #hospitalisation and #death: a Danish nationwide cohort study, www.thelancet.com/journals/lan...
...vaccine offered good protection over a 4-month period against COVID-19 hospitalisation and death.
...vaccine offered good protection over a 4-month period against COVID-19 hospitalisation and death.
Effects of #LP81 - adapted #mRNA #vaccination on #SARS-CoV-2 variant #neutralisation, etidiohnew.blogspot.com/2025/11/effe...
Effects of #LP81 - adapted #mRNA #vaccination on #SARS-CoV-2 variant #neutralisation
etidiohnew.blogspot.com
November 22, 2025 at 9:38 AM
Effects of #LP81 - adapted #mRNA #vaccination on #SARS-CoV-2 variant #neutralisation, etidiohnew.blogspot.com/2025/11/effe...